Pierre Devaux

Pharmacist – CEO Theraxel-Point Forty Five

Theraxel-Point Forty Five is a Company specialized in consulting, technical assistance, regulatory audits and training around the control of the chemical risk, Microbiological, particulate and pyrogenic for non-sterile, sterile and biotechnological pharmaceutical industries as well as related industries such as cosmetic industries.

Pierre Devaux is a specialist in Part I, Annex 1 and Annex 15 of the European GMP, ICHQ9 and FDA guidelines on aseptic and validation processes and ISO22716

He has the following experience:

  • 6 years as responsible for the quality control laboratories and the management of the environmental monitoring of the ZAC of the Excelvision Fareva French site;
  • 5 years as Qualified Person/Quality Director of the ACM Pharma French laboratory, while carrying out consulting missions via the company UPS Consultants.
  • Head within the French Association A3P of the Common Interest Group on GMP Annex 15 and Cleaning Validation.
  • Speaker for ISPE Nordic and Trainer for A3P Services as well as for Key2Compliance®.
Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

Related courses to Pierre Devaux

New perspectives on Cross Contamination and Cleaning validation


Decontamination Process and the new Draft of the EU GMP Annex 1


Cleaning validation of pharmaceutical process equipment

Decontamination process and validation


EU Annex 1 - Manufacture of Sterile Medicinal Products

Contamination Control Strategy



For your best experience are we using cookies on this website.